Enlivex Therapeutics
ENLV
ENLV
14 hedge funds and large institutions have $2.05M invested in Enlivex Therapeutics in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$39K | |
| 2 | +$27K | |
| 3 | +$27K | |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$2K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$2K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$486K | |
| 3 | -$54K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$17.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |